Serum Levels of Interleukin-13 Increase in Subjects with Insulin Resistance but Do Not Correlate with Markers of Low-Grade Systemic Inflammation

Figure 1

Representative dot plots showing percentages of proinflammatory and anti-inflammatory monocytes in patients with insulin resistance and noninsulin-resistant controls. (a) and (b) illustrate representative flow cytometry dot plots showing percentages of proinflammatory monocytes that express CD11c but do not express CD206 (Mon-CD11c⁺CD206⁻) in controls and insulin-resistant patients, respectively. (c) and (d) illustrate representative dot plots showing percentages of anti-inflammatory monocytes that express CD206 but do not express CD11c (Mon-CD11c⁻CD206⁺) in controls and insulin-resistant patients, respectively. Dot plot quantification can be seen in Table 1.

(a)

(b)

(c)

(d)